Global Reach for Clinical Trials: Why the Philippines Is a Strategic Advantage
GLSA offers global reach for clinical trials through our trusted network of Clinical Research Organizations (CROs). In particular, this article highlights the advantages of conducting clinical trials in the Philippines—a region that continues to emerge as a strategic hub for XUS studies.
Through our partnership with a leading Philippine CRO, GLSA brings geographic diversity, regulatory efficiency, and full-service clinical trial capabilities. From clinical trial management to site operations and trial support services, the Philippines offers compelling advantages for sponsors seeking speed, quality, and access to diverse patient populations.
We are excited to collaborate with this partner, who is uniquely positioned to deliver both expertise and diversity for global clinical trials.
Why the Philippines for Clinical Research?
The Philippines represents a “sweet spot” for clinical research for several important reasons.
First, the country’s population of more than 109 million provides a large and accessible pool of potential trial participants. In addition, a high birth rate supports strong enrollment opportunities for pediatric studies.
Moreover, the healthcare system is largely out-of-pocket. As a result, many patients have limited prior exposure to investigational or branded therapies commonly used in more developed markets. This creates a valuable opportunity for treatment-naïve populations and supports cleaner data collection in many trial designs.
Equally important, the regulatory environment has improved significantly. Studies can often begin within 60 days—and in some cases as quickly as 30 days. Furthermore, more than 46 Ethics Review Boards (ERBs) are available to review and approve clinical trial protocols, helping to reduce start-up timelines.
Taken together, these factors make the Philippines a strong option for XUS trials. Our partner is ready to explore what’s possible with you.
👉 Learn more here: Clinical Trials in the Philippines.
Expertise and Full-Service Capabilities
In the Philippines, protocols can move quickly from approval to activation. Our partner manages clinical trials across Phase I through Phase IV and brings deep expertise in multiple therapeutic areas, including Oncology, Vaccines, and Infectious Diseases.
Additionally, access to a large treatment-naïve population provides a distinct recruitment advantage.
Core Services Include:
-
Clinical Trial Management
-
Post-Marketing Surveillance (PMS) and Real-World Evidence (RWE)
-
Site Management
-
Clinical Trial Support Services
Clinical Trial Management
Managing clinical trials involves complex coordination across sites, sponsors, and regulators. To address this, our partner has developed a comprehensive drug and device trial management solution that streamlines and automates trial operations.
As a result, sponsors benefit from improved oversight, efficiency, and consistency—helping studies stay on track and meet key milestones.
Post-Marketing Surveillance (PMS) and Real-World Evidence (RWE)
Safety and efficacy remain top priorities throughout the product lifecycle. Accordingly, products are continuously monitored for adverse events and evaluated using real-world evidence to assess performance outside controlled trial settings.
GLSA’s partner provides end-to-end support, from pre-regulatory planning and study start-up through close-out and final clinical study reporting.
Site Management Excellence
The partner’s Site Management Organization (SMO) platform delivers comprehensive support for research sites and Principal Investigators.
Site Management Capabilities:
-
Contract negotiations
-
IRB/IEC submissions and approvals*
-
Patient counseling, recruitment, and retention
-
Patient follow-up
-
Informed Consent Form (ICF) translation into vernacular languages*
-
Site initiation and trial close-out
-
Trial document archival and maintenance
-
Serious adverse event (SAE) reporting
-
Protocol and ICH-GCP compliance monitoring
-
Investigator advisement and training
-
International site accreditation
-
Research site networking
Clinical Trial Support Services
Finally, pharmacovigilance plays a critical role in drug development. In the Philippines, you work with a partner that delivers end-to-end PV project management.
This ensures your pharmacovigilance program meets the highest standards for patient safety, regulatory compliance, and operational excellence.
Moving Forward
The advantages of running clinical trials in the Philippines are clear. Combined with this CRO’s full-spectrum capabilities, GLSA offers sponsors a powerful option for accelerating global development programs.
👉 Explore the possibilities here: Clinical Trials in the Philippines.
About GLSA
Global Life Sciences Alliance (GLSA) connects biotechs, pharma, CROs, and clinical research sites with the right experts, advisors, and solutions to accelerate development and reduce risk. With a network of more than 200 trusted partners spanning pre-clinical and clinical research, GLSA offers flexible, cost-effective access to specialized expertise and services that support early-stage biotechs, mid-size pharma, and global pharmaceutical companies.
When you need trusted, global resources to accelerate your research, GLSA helps you scale smarter and move you forward with confidence.
To learn how GLSA can support your organization, connect with Denise McNerney or Chris Matheus for a conversation about your goals and challenges.